Oral Apomorphine Delivery from Solid Lipid Nanoparticles with Different Monostearate Emulsifiers: Pharmacokinetic and Behavioral Evaluations

Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art

Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759 · see citing works

Effect of pegylation on pharmaceuticals

Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431 · see citing works

Nanoparticulate systems for brain delivery of drugs.

Kreuter, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00122-8 · Cited by 1,107 · see citing works

Nanoparticulate systems for brain delivery of drugs

Kreuter, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.015 · Cited by 958 · see citing works

Solid lipid nanoparticles (SLN) for controlled drug delivery – Drug release and release mechanism

Mühlen, A. Z., Schwarz, C., & Mehnert, W. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00150-1 · Cited by 945 · see citing works

The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments

Schwarting, R. K. W., & Huston, J. P. (1996) · Progress in Neurobiology · doi:10.1016/s0301-0082(96)00040-8 · Cited by 741 · see citing works

Potential of solid lipid nanoparticles in brain targeting.

Kaur, I. P., Bhandari, R., Bhandari, S., & Kakkar, V. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.018 · Cited by 615 · see citing works

Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles

Venkateswarlu, V., & Manjunath, K. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.01.005 · Cited by 558 · see citing works

Lipid nanoparticles as vehicles for topical psoralen delivery: Solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC)

Fang, J., Fang, C.-L., Liu, C.-H., & Su, Y.-H. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.05.008 · Cited by 518 · see citing works

Correlation between long-term stability of solid lipid nanoparticles (SLN™) and crystallinity of the lipid phase

Freitas, C., & Müller, R. H. (1999) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00074-5 · Cited by 484 · see citing works

Long-circulating pegylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery.

Calvo, P., Gouritin, B., Chacun, H., Desmaële, D., D'Angelo, J., Noel, J.-P., Georgin, D., Fattal, E., Andreux, J. P., & Couvreur, P. (2001) · Pharmaceutical Research · doi:10.1023/a:1010931127745 · Cited by 443 · see citing works

Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN)

Helgason, T., Awad, T. S., Kristbergsson, K., McClements, D. J., & Weiss, J. (2009) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2009.03.012 · Cited by 341 · see citing works

Body Distribution of Camptothecin Solid Lipid Nanoparticles After Oral Administration

Yang, S., Zhu, J., Yu, L., Liang, B., & Yang, C. (1999) · Pharmaceutical Research · doi:10.1023/a:1018888927852 · Cited by 324 · see citing works

Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN®) versus drug nanocrystals

Müller, R. H., Runge, S., Ravelli, V., Mehnert, W., Thünemann, A. F., & Souto, E. B. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.045 · Cited by 304 · see citing works

Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery

Paliwal, R., Paliwal, S. R., Vaidya, B., Khatri, K., Goyal, A. K., Mishra, N., Mehta, A., & Vyas, S. P. (2008) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2008.08.003 · Cited by 288 · see citing works

Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin

Zhang, N., Ping, Q. N., Huang, G., Xu, W., Cheng, Y., & Han, X. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.07.026 · Cited by 286 · see citing works

Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification

Yuan, H., Wang, L., Du, Y., You, J., Hu, F., & Zeng, S. (2007) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2007.06.011 · Cited by 216 · see citing works

Stability of lipid excipients in solid lipid nanoparticles☆

Radomska-Soukharev, A. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.004 · Cited by 206 · see citing works

Cyclosporine-loaded solid lipid nanoparticles (SLN®): Drug–lipid physicochemical interactions and characterization of drug incorporation

Müller, R. H. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.07.006 · Cited by 199 · see citing works

A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery

García-Fuentes, M., Prego, C., Torres, D., & Alonso, M. J. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.02.008 · Cited by 171 · see citing works

Recovery of erectile function by the oral administration of apomorphine

Heaton, J. P. W., Morales, Á., ADAMS, M. A., Johnston, B., & El‐Rashidy, R. (1995) · Urology · doi:10.1016/0090-4295(95)80005-0 · Cited by 170 · see citing works

Recent Advances and Patents on Solid Lipid Nanoparticles

Sawant, K. K., & Dodiya, S. (2008) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221108784534081 · Cited by 153 · see citing works

Solid Lipid Nanoparticles in Lymph and Plasma After Duodenal Administration to Rats

Bargoni, A., Cavalli, R., Caputo, O., Fundaro', A., Gasco, M. R., & Zara, G. P. (1998) · Pharmaceutical Research · doi:10.1023/a:1011975120776 · Cited by 148 · see citing works

Pharmacokinetics and Tissue Distribution of Idarubicin-Loaded Solid Lipid Nanoparticles After Duodenal Administration to Rats

Zara, G. P., Bargoni, A., Cavalli, R., Fundaro', A., Vighetto, D., & Gasco, M. R. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10129 · Cited by 143 · see citing works

Triglyceride-Based Microemulsion for Intravenous Administration of Sparingly Soluble Substances

von Corswant, C., Thorén, P., & Engström, S. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970258w · Cited by 121 · see citing works

Solid Lipid Nanoparticles Incorporating Melatonin as New Model for Sustained Oral and Transdermal Delivery Systems

Priano, L., Esposti, D., Esposti, R., Castagna, G., Medici, C. D., FRASCHINI, F., Gasco, M. R., & Mauro, A. (2007) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2007.809 · Cited by 112 · see citing works

Preparation and Characterization of Solid Lipid Nanoparticles Containing Silibinin

Zhang, J. Q., Liu, J., Li, X. L., et al. (2007) · Drug Delivery · doi:10.1080/10717540701203034 · Cited by 99 · see citing works

Lipid–drug conjugate nanoparticles of the hydrophilic drug diminazene—cytotoxicity testing and mouse serum adsorption

Olbrich, C., Gessner, A., Schröder, W., et al. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.02.024 · Cited by 94 · see citing works

Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection

Wang, J., Liu, K., Sung, K. C., Tsai, C.-Y., & Fang, J. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.06.008 · Cited by 87 · see citing works

Improvement of cefpodoxime proxetil oral absorption in rats by an oil-in-water submicron emulsion

Nicolaos, G. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00365-x · Cited by 84 · see citing works

Short-Term Supplementation with Plant Extracts Rich in Flavonoids Protect Nigrostriatal Dopaminergic Neurons in a Rat Model of Parkinson's Disease

Datla, K. P., Zbarsky, V., Rai, D., Parkar, S., Osakabe, N., Aruoma, O. I., & Dexter, D. T. (2007) · Journal of the American College of Nutrition · doi:10.1080/07315724.2007.10719621 · Cited by 83 · see citing works

Methotrexate Loaded Solid Lipid Nanoparticles (SLN) for Effective Treatment of Carcinoma

Kandasamy, R., Manickam, S., & Ganeshkumar, P. A. (2006) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2006.457 · Cited by 78 · see citing works

Preparation of a Dispersible PEGylate Nanostructured Lipid Carriers (NLC) Loaded with 10-Hydroxycamptothecin by Spray-Drying

Zhang, X., Pan, W., Gan, L., et al. (2008) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.56.1645 · Cited by 75 · see citing works

Intranasal bioavailability of apomorphine from carboxymethylcellulose-based drug delivery systems

Ugwoke, M. I., Kaufmann, G., Verbeke, N., et al. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00434-8 · Cited by 73 · see citing works

Cellular immune response to intrastriatally implanted allogeneic bone marrow stromal cells in a rat model of Parkinson's disease

Camp, D. M., Loeffler, D. A., Farrah, D. M., Borneman, J. N., & LeWitt, P. A. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-17 · Cited by 72 · see citing works

A study of the formulation design of acoustically active lipospheres as carriers for drug delivery

Fang, J., Hung, C., Liao, M.-H., & Chien, C.-C. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.01.008 · Cited by 70 · see citing works

Apomorphine in Dopaminergic Therapy

Subramony, J. A. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060012c · Cited by 65 · see citing works

The pharmacology and clinical pharmacokinetics of apomorphine SL

Argiolas, A., & Hedlund, H. (2001) · British Journal of Urology · doi:10.1046/j.1464-4096.2001.00124.x · Cited by 49 · see citing works

Apomorphine for the acute treatment of “off” episodes in Parkinson's disease

Stacy, M. A., & Silver, D. E. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.07.016 · Cited by 46 · see citing works

Unilateral implantation of dopamine-loaded biodegradable hydrogel in the striatum attenuates motor abnormalities in the 6-hydroxydopamine model of hemi-parkinsonism

Karuppagounder, S. S., Saravanan, K. S., Chandra, G., et al. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.06.025 · Cited by 44 · see citing works

The effects of systemic, intrastriatal, and intrapallidal injections of caffeine and systemic injections of A2A and A1 antagonists on forepaw stepping in the unilateral 6-OHDA-lesioned rat

Kelsey, J. E., Langelier, N. A., Oriel, B. S., & Reedy, C. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1319-0 · Cited by 36 · see citing works

Mode of action of a new oral treatment for erectile dysfunction: apomorphine SL

Rampin, O. (2001) · British Journal of Urology · doi:10.1046/j.1464-4096.2001.00125.x · Cited by 29 · see citing works

Docosahexaenoic Acid Ethyl Ester Enhances 6-Hydroxydopamine-Induced Neuronal Damage by Induction of Lipid Peroxidation in Mouse Striatum

Kabuto, H., Amakawa, M., Mankura, M., Yamanushi, T. T., & Mori, A. (2009) · Neurochemical Research · doi:10.1007/s11064-008-9909-0 · Cited by 27 · see citing works

Effect of Oil-in-Water Submicron Emulsion Surface Charge on Oral Absorption of a Poorly Water-Soluble Drug in Rats

Poullain-Termeau, S., Crauste–Manciet, S., Brossard, D., et al. (2008) · Drug Delivery · doi:10.1080/10717540802321792 · Cited by 21 · see citing works

An integrated pharmacokinetic–pharmacodynamic approach to optimization of R-apomorphine delivery in Parkinson's disease

Danhof, M. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00033-7 · Cited by 19 · see citing works

Apomorphine-induced differences in cortical and striatal EEG and their glutamatergic mediation in 6-hydroxydopamine-treated rats

Vorobyov, V., & Sengpiel, F. (2008) · Experimental Brain Research · doi:10.1007/s00221-008-1519-1 · Cited by 16 · see citing works

[Hypoglycemic effect of polysaccharide-coated insulin liposomes after oral administration in mice].

Wu, Z., Ping, Q. N., Lai, J., et al. (2003) · PubMed · Cited by 11 · see citing works

Opposite vascular activity of (R)-apomorphine and its oxidised derivatives. Endothelium-dependent vasoconstriction induced by the auto-oxidation metabolite

Abarca, B., Ballesteros, R., Bielsa, P., et al. (2003) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(03)00057-6 · Cited by 8 · see citing works

Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles

Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645 · see citing works

Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB

Satapathy, M. K., Yen, T.-L., Jan, J.-S., Tang, R.-D., Wang, J.-Y., Taliyan, R., & Yang, C.-H. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081183 · Cited by 318 · see citing works

Nanoparticle technology for treatment of Parkinson’s disease: The role of surface phenomena in reaching the brain

Leyva-Gómez, G., Cortés, H., Magaña, J. J., Leyva-García, N., Quintanar-Guerrero, D., & Florán, B. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.02.009 · Cited by 102 · see citing works

Therapeutics, imaging and toxicity of nanomaterials in the central nervous system.

Nunes, A., Al-Jamal, K. T., & Kostarelos, K. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.026 · Cited by 75 · see citing works

Time-course of apomorphine in the brain of the immature rat after apomorphine injection.

Al, S., Lal, S., & Soukes, T. L. (1976) · PubMed · Cited by 18 · see citing works

Apomorphine-induced aggression in the rat

McKenzie, G. M. (1971) · Brain Research · doi:10.1016/0006-8993(71)90284-8 · Cited by 88 · see citing works

Apomorphine: Effect on Growth Hormone

MAANY, I., Frazer, A., & MENDELS, J. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-40-1-162 · Cited by 45 · see citing works

Effect of lipid on physicochemical properties of solid lipid nanoparticle of paclitaxel

Baek, J.-S., Shin, S., & Cho, C. (2012) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-012-0038-z · Cited by 20 · see citing works

[Apomorphine for treatment of "off-periods" in Parkinson's disease].

Zoldan, J., Merims, D., Kuritzky, A., et al. (1999) · PubMed